AstraZeneca PLC (AZN.L)

Ionis' Q3 Earnings and Revenues Beat Estimates, New Launches in Focus

IONS reports better-than-expected top and bottom-line numbers for the third quarter of 2024.

• 
  Ionis Pharmaceuticals (IONS) Reports Q3 Loss, Tops Revenue Estimates

  Zacks
• 
  Compared to Estimates, Ionis Pharmaceuticals (IONS) Q3 Earnings: A Look at Key Metrics

  Zacks

Unveiling Astrazeneca (AZN) Q3 Outlook: Wall Street Estimates for Key Metrics

Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Astrazeneca (AZN), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2024.